EXOC1L
gene geneOn this page
Summary
EXOC1L (exocyst complex component 1 like, HGNC:53433) is a protein-coding gene on chromosome 4q12, encoding Exocyst complex component 1-like (A0A1B0GW35).
At a glance
- MANE Select transcript:
NM_001351574
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53433 |
| Approved symbol | EXOC1L |
| Name | exocyst complex component 1 like |
| Location | 4q12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000250821 |
| Ensembl biotype | protein_coding |
| Entrez | 644145 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 nonsense_mediated_decay, 1 protein_coding
ENST00000504250, ENST00000636125
RefSeq mRNA: 2 — MANE Select: NM_001351574
NM_001351574, NM_001351575
CCDS: CCDS87223
Canonical transcript exons
ENST00000636125 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003793080 | 55837085 | 55837489 |
| ENSE00003796353 | 55831334 | 55831464 |
| ENSE00003799335 | 55819790 | 55820147 |
Expression profiles
Bgee: expression breadth broad, 52 present calls, max score 48.72.
Top tissues by expression
109 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| caudate nucleus | UBERON:0001873 | 48.72 | gold quality |
| adrenal tissue | UBERON:0018303 | 48.19 | gold quality |
| putamen | UBERON:0001874 | 46.63 | gold quality |
| nucleus accumbens | UBERON:0001882 | 44.56 | gold quality |
| hypothalamus | UBERON:0001898 | 43.78 | gold quality |
| prefrontal cortex | UBERON:0000451 | 42.14 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.31 | gold quality |
| bone marrow cell | CL:0002092 | 41.16 | gold quality |
| right testis | UBERON:0004534 | 39.75 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 39.48 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 38.92 | gold quality |
| omental fat pad | UBERON:0010414 | 38.36 | gold quality |
| left testis | UBERON:0004533 | 38.34 | gold quality |
| testis | UBERON:0000473 | 37.79 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 37.59 | silver quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 37.48 | gold quality |
| substantia nigra | UBERON:0002038 | 37.18 | gold quality |
| amygdala | UBERON:0001876 | 36.78 | gold quality |
| temporal lobe | UBERON:0001871 | 36.70 | gold quality |
| frontal cortex | UBERON:0001870 | 36.62 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| brain | UBERON:0000955 | 36.26 | gold quality |
| pituitary gland | UBERON:0000007 | 35.52 | silver quality |
| cerebral cortex | UBERON:0000956 | 35.49 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| Ammon’s horn | UBERON:0001954 | 34.43 | gold quality |
| bone marrow | UBERON:0002371 | 34.30 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| adipose tissue | UBERON:0001013 | 33.17 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.46 |
Regulation
Is transcription factor: no
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | exoc1l | ENSDARG00000070320 |
| mus_musculus | Exoc1l | ENSMUSG00000091204 |
| rattus_norvegicus | Exoc1l | ENSRNOG00000050100 |
| drosophila_melanogaster | Sec3 | FBGN0266669 |
| caenorhabditis_elegans | WBGENE00018703 |
Paralogs (2): EXOC1 (ENSG00000090989), STXBP6 (ENSG00000168952)
Protein
Protein identifiers
Exocyst complex component 1-like — A0A1B0GW35 (reviewed: A0A1B0GW35)
All UniProt accessions (2): A0A1B0GW35, A0A1B0GV28
RefSeq proteins (2): NP_001338503, NP_001338504 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028258 | Sec3-PIP2_bind | Domain |
Pfam: PF15277
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GW35-F1 | 89.19 | 0.73 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 2 (showing top):
chr4q12, ZNF563_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
534 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EXOC1L | OSBPL1A | Q9BXW6 | 507 |
| EXOC1L | HSD17B13 | Q7Z5P4 | 407 |
| EXOC1L | FXYD6 | Q9H0Q3 | 401 |
| EXOC1L | A0A087WZ82 | A0A087WZ82 | 401 |
| EXOC1L | LNP1 | A1A4G5 | 397 |
| EXOC1L | TDRD1 | Q9BXT4 | 387 |
| EXOC1L | HTR1F | P30939 | 385 |
| EXOC1L | RARRES1 | P49788 | 379 |
| EXOC1L | IQSEC2 | Q5JU85 | 376 |
| EXOC1L | IL31RA | Q8NI17 | 365 |
| EXOC1L | C9J5N1 | C9J5N1 | 351 |
| EXOC1L | EXOC2 | Q96KP1 | 349 |
| EXOC1L | EXOC4 | Q96A65 | 349 |
| EXOC1L | EXOC7 | Q9UPT5 | 349 |
| EXOC1L | EXOC8 | Q8IYI6 | 349 |
| EXOC1L | EXOC5 | O00471 | 349 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GW35, A6QNM3, B0R034, B1ANS9, B9EK06, D2KC46, D3ZY60, F1MS15, F1P065, F1REV3, O00522, O15091, O75747, P10911, P58069, Q008S8, Q14449, Q14D04, Q15283, Q32NR9, Q45GW3, Q4R366, Q4R6T7, Q5H9U9, Q5K651, Q5PQS3, Q5XGX5, Q5XIZ9, Q5ZLD2, Q60862, Q63713, Q69Z37, Q6DCF6, Q6S5J6, Q6TNJ1, Q75PQ8, Q80W71, Q86VD1, Q86YR7, Q8C5W4
Diamond homologs: A0A1B0GW35, B9EK06, Q8R3S6, Q9NV70, Q20678, Q2YDL1, Q8NFX7, Q8R3T5, Q9VVG4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
1145 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:55831448:G:A | G79E | 0.999 |
| 4:55837153:A:C | K107N | 0.999 |
| 4:55837153:A:T | K107N | 0.999 |
| 4:55837167:G:C | R112P | 0.999 |
| 4:55820138:T:C | C38R | 0.998 |
| 4:55820140:T:G | C38W | 0.998 |
| 4:55831433:T:C | L74P | 0.998 |
| 4:55831447:G:A | G79R | 0.998 |
| 4:55831447:G:C | G79R | 0.998 |
| 4:55831448:G:T | G79V | 0.998 |
| 4:55837151:A:G | K107E | 0.998 |
| 4:55837152:A:T | K107I | 0.998 |
| 4:55831417:T:A | W69R | 0.997 |
| 4:55831417:T:C | W69R | 0.997 |
| 4:55831433:T:A | L74Q | 0.997 |
| 4:55837098:T:C | F89S | 0.997 |
| 4:55837104:T:C | L91P | 0.997 |
| 4:55837134:C:A | A101E | 0.997 |
| 4:55837139:A:C | S103R | 0.997 |
| 4:55837141:C:A | S103R | 0.997 |
| 4:55837141:C:G | S103R | 0.997 |
| 4:55820136:T:C | L37P | 0.996 |
| 4:55831433:T:G | L74R | 0.996 |
| 4:55837164:C:A | A111D | 0.996 |
| 4:55837224:T:C | F131S | 0.996 |
| 4:55837298:T:C | C156R | 0.996 |
| 4:55820139:G:A | C38Y | 0.995 |
| 4:55831442:T:A | I77N | 0.995 |
| 4:55837085:G:C | D85H | 0.995 |
| 4:55837154:T:C | Y108H | 0.995 |
dbSNP variants (sampled 300 via entrez): RS10000711 (4:55817850 A>T), RS1000120129 (4:55825450 A>T), RS1000463253 (4:55818888 C>T), RS1000526014 (4:55827616 C>T), RS1000557213 (4:55827943 C>T), RS1000712872 (4:55820916 G>A), RS1001025264 (4:55820805 C>T), RS10014844 (4:55826665 T>A), RS1001695382 (4:55833365 A>C), RS1001728933 (4:55835227 A>G), RS1002009213 (4:55836704 C>A,T), RS1002104022 (4:55836389 T>C), RS1002181557 (4:55823771 C>A,T), RS1002222160 (4:55834951 A>T), RS1002293398 (4:55834715 C>A,G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.